LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun ...
GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...
GSK and the University of Oxford have entered ... The new presentation claims to simplify administration by eliminating the need to mix a powder antigen with a liquid adjuvant.
GSK has announced that the European Medicines Agency (EMA) has accepted its regulatory application for a prefilled syringe presentation of Shingrix ...